Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
20 juin 2024 01h00 HE
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines, is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
20 juin 2024 01h00 HE
|
Avextra AG
Avextra, der führende europäische vertikal integrierte Hersteller und Entwickler von Medikamenten auf Cannabisbasis, erweitert nach Abschluss seiner Finanzierungsrunde im ersten Quartal 2024 seine...
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
20 juin 2024 01h00 HE
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients
18 oct. 2023 07h00 HE
|
Avextra AG
Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data with the...
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
17 mai 2023 07h00 HE
|
Avextra AG
Avextra has successfully exported EU-GMP standardised cannabis extracts manufactured at its German facility to its distribution partner in ItalyAvextra extracts are the first Made in Germany products...
C15 Solutions Anticipates Substantial Growth in European Cannabis Market Through Innovative Tech Platform
20 avr. 2023 07h00 HE
|
C15 Solutions
Oakville, Ontario, April 20, 2023 (GLOBE NEWSWIRE) -- C15 Solutions (“C15” or the “Company”), a technology vendor delivering a customized eQMS (‘electronic Quality Management System’) for the...
Avextra AG Announces Closing of EU 17 Million Capital Raise
15 mars 2023 08h00 HE
|
Avextra AG
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round currently in preparation. ...
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
08 févr. 2023 09h00 HE
|
Avextra AG
Avextra successfully exported EU-GMP standardised cannabis extracts manufactured in its German facility to its distribution partner in the United Kingdom Export is a significant milestone that...
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
04 oct. 2022 07h00 HE
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring...
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
29 sept. 2022 01h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia and SANDWICH, United Kingdom, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” or the “Company”), is pleased to announce the opening of its recently...